The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I STTR Grant Entitled "PROTACS Against Nef as a Functional Cure for HIV Infection"

 

Doylestown, PA. June 22, 2020 - FCCDC is pleased to announce it has been awarded a Phase I STTR research grant from NIAID/NIH together with Prof. Tom Smithgall of the University of Pittsburg, entitled "PROTACS Against Nef as a Functional Cure for HIV Infection."